Review article: bifidobacteria as probiotic agents – physiological effects and clinical benefits

By C. Picard, J. Fioramonti, A. François, T. Robinson, F. Neant, C. Matuchansky. Alimentary Pharmacology and Therapeutics, 2005

637 citations recorded by the source corpus.

Subfields: Food Science, Genetics, Nutrition and Dietetics

View Paper: https://www.semanticscholar.org/paper/3415e632f5e8ea08d40d3723ced2514dbf5899fa

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Food Science

1. D. van Sinderen
2. F. Bäckhed

In Nutrition and Dietetics

1. F. Bäckhed

Citations in the corpus

• Bifidobacteria can protect from enteropathogenic infection through production of acetate (2011, methodology): “A target vector containing two 1-kb genomic fragments flanking the spectinomycin-resistant gene was constructed with the plasmid pBluescript II SK (1).”
• Bifidobacteria and Their Role as Members of the Human Gut Microbiota (2016, background): “Bifidobacteria have been commercially exploited as probiotic agents due to their associated health benefits and GRAS (Generally Recognised As Safe) status (Picard et al., 2005).”
• Bifidobacteria or fiber protect against diet-induced microbiota-mediated colonic mucus deterioration (2017, background): “Bifidobacterium strains have long been used as probiotics (Picard et al., 2005) and have several beneficial effects, including preventing translocation of enteropathogenic E.”